George Thomas, PhD MBA
President & CEO
Dr. Thomas has over 18 years of experience in research leadership and strategic planning in the areas of bio-pharma R&D, molecular diagnostics and therapeutic target discovery and validation. Dr. Thomas has held senior executive positions at Torrent Pharmaceuticals Research Centre, India, where he led teams responsible for setting up in vitro and in vivo assays, managing outsourced studies, pharmacokinetic and toxicological studies and clinical trials. In addition, he has been responsible for the scientific evaluation of various assays/technologies for license or acquisition from industry and academia. In his role with CentreStone Ventures, a life science focused venture capital fund, Dr. Thomas has been actively involved in the scientific assessment and feasibility of various business opportunities, sourcing new opportunities, and taking leadership positions with investee companies. Dr. Thomas received his Master of Pharmacy degree and Ph.D. from the Birla Institute of Technology and Sciences, Pilani, India. He received his post-doctoral training at the Faculty of Medicine, University of Toronto. He was awarded an MBA from the Ivey School of Business, London, Ontario.
James Kinley, CA
Mr. Kinley is responsible for the financial operations of Marsala through its contract with Genesys Venture, Inc. Previously, Mr. Kinley was Manager, Financial Reporting at Manitoba Telecom Services Ltd. (MTS). His responsibilities included the review and distribution of external quarterly and annual financial statements, internal financial statements and board reporting packages. He was also significantly involved in the conversion from Canadian Generally Accepted Accounting Principles (GAAP) to International Financial Reporting Standards (IFRS). Mr.Kinley has extensive experience working with publicly traded entities, having provided financial reporting services for a number of stock exchange listed real estate investment trusts (REITs) from 2006 to 2008. Prior to this time he was an Audit Senior at Ernst & Young, LLP. Mr Kinley is a Chartered Accountant and holds a B.Comm (Honours) degree from the I.H. Asper School of Business (University of Manitoba).
Jan-Ake Westin - VP
Jan-Ake Westin is an accomplished clinical scientist and business executive with close to 40 years experience in the life science industry. He is highly skilled in Clinical Program Development, Effective Conduct of Clinical Trials, Good Clinical Practices, and topics related to Life Science Business Strategies.
Mr. Westin received his Pharmacy Degree and M.Sc. in Social Pharmacy from the University of Uppsala, Sweden. He has a long list of post-graduate studies which include Business Management, Clinical Trial Methodology, Pharmacokinetics, and Good Clinical Practices. He has held major management positions in several of the leading Pharmaceutical, Biotechnology and Contract Research Organizations in the US, Canada and Europe.